Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 126

1.

18F-fluorodeoxyglucose positron emission tomography in the management of patients with thymic epithelial tumors.

Thomas A, Mena E, Kurdziel K, Venzon D, Khozin S, Berman AW, Choyke P, Szabo E, Rajan A, Giaccone G.

Clin Cancer Res. 2013 Mar 15;19(6):1487-93. doi: 10.1158/1078-0432.CCR-12-2929. Epub 2013 Feb 4.

2.

Utility of 18F-fluorodeoxyglucose positron emission tomography for distinguishing between the histological types of early stage thymic epithelial tumours.

Eguchi T, Yoshida K, Hamanaka K, Shiina T, Koizumi T, Kawakami S, Oguchi K, Amano J.

Eur J Cardiothorac Surg. 2012 May;41(5):1059-62. doi: 10.1093/ejcts/ezr144. Epub 2011 Dec 21.

PMID:
22219437
3.

The utility of [18F]-fluorodeoxyglucose positron emission tomography-computed tomography in thymic epithelial tumours.

Fukumoto K, Taniguchi T, Ishikawa Y, Kawaguchi K, Fukui T, Kato K, Matsuo K, Yokoi K.

Eur J Cardiothorac Surg. 2012 Dec;42(6):e152-6. doi: 10.1093/ejcts/ezs527. Epub 2012 Sep 28.

PMID:
23024234
4.

¹⁸F-fluorodeoxyglucose positron emission tomography for evaluation of thymic epithelial tumors: utility for World Health Organization classification and predicting recurrence-free survival.

Seki N, Sakamoto S, Karube Y, Oyaizu T, Ishihama H, Chida M.

Ann Nucl Med. 2014 Apr;28(3):257-62. doi: 10.1007/s12149-014-0804-2. Epub 2014 Jan 16.

PMID:
24430867
5.

FDG PET-CT aids in the preoperative assessment of patients with newly diagnosed thymic epithelial malignancies.

Benveniste MF, Moran CA, Mawlawi O, Fox PS, Swisher SG, Munden RF, Marom EM.

J Thorac Oncol. 2013 Apr;8(4):502-10. doi: 10.1097/JTO.0b013e3182835549.

6.

Characterization of thymic lesions with F-18 FDG PET-CT: an emphasis on epithelial tumors.

Liu Y.

Nucl Med Commun. 2011 Jul;32(7):554-62. doi: 10.1097/MNM.0b013e328345b984. Review.

PMID:
21403583
7.

Is a positron emission tomography-computed tomography scan useful in the staging of thymic epithelial neoplasms?

Viti A, Terzi A, Bianchi A, Bertolaccini L.

Interact Cardiovasc Thorac Surg. 2014 Jul;19(1):129-34. doi: 10.1093/icvts/ivu068. Epub 2014 Mar 19. Review.

8.

Combined imaging with 18F-FDG-PET/CT and 111In-labeled octreotide SPECT for evaluation of thymic epithelial tumors.

De Luca S, Fonti R, Palmieri G, Federico P, Del Prete G, Pacelli R, Pace L, De Placido S, Salvatore M, Del Vecchio S.

Clin Nucl Med. 2013 May;38(5):354-8. doi: 10.1097/RLU.0b013e318286bd84.

PMID:
23486323
9.

Usefulness of 18-F FDG PET/CT in the pre-treatment evaluation of thymic epithelial neoplasms.

Terzi A, Bertolaccini L, Rizzardi G, Luzzi L, Bianchi A, Campione A, Comino A, Biggi A.

Lung Cancer. 2011 Nov;74(2):239-43. doi: 10.1016/j.lungcan.2011.02.018. Epub 2011 Mar 25.

PMID:
21439670
10.

[18F]FDG positron emission tomography/computed tomography and multidetector computed tomography roles in thymic lesion treatment planning.

Travaini LL, Petralia G, Trifirò G, Ravasi L, Galetta D, Carbone G, Falcini F, Spaggiari L, Bellomi M, Paganelli G.

Lung Cancer. 2008 Sep;61(3):362-8. doi: 10.1016/j.lungcan.2008.01.019. Epub 2008 Mar 20.

PMID:
18358558
11.

Usefulness of fluorine-18 fluorodeoxyglucose-positron emission tomography in management strategy for thymic epithelial tumors.

Matsumoto I, Oda M, Takizawa M, Waseda R, Nakajima K, Kawano M, Mochizuki T, Ikeda H, Watanabe G.

Ann Thorac Surg. 2013 Jan;95(1):305-10. doi: 10.1016/j.athoracsur.2012.09.052. Epub 2012 Nov 28.

PMID:
23200236
12.

The role of [¹⁸F]fluorodeoxyglucose positron emission tomography in thymic epithelial tumors.

Kaira K, Sunaga N, Ishizuka T, Shimizu K, Yamamoto N.

Cancer Imaging. 2011 Nov 30;11:195-201. doi: 10.1102/1470-7330.2011.0028. Review.

13.

Is (18)F-FDG PET useful in predicting the WHO grade of malignancy in thymic epithelial tumors? A meta-analysis.

Treglia G, Sadeghi R, Giovanella L, Cafarotti S, Filosso P, Lococo F.

Lung Cancer. 2014 Oct;86(1):5-13. doi: 10.1016/j.lungcan.2014.08.008. Epub 2014 Aug 18. Review.

PMID:
25175317
14.

Quantitative analysis of response to treatment with erlotinib in advanced non-small cell lung cancer using 18F-FDG and 3'-deoxy-3'-18F-fluorothymidine PET.

Kahraman D, Scheffler M, Zander T, Nogova L, Lammertsma AA, Boellaard R, Neumaier B, Ullrich RT, Holstein A, Dietlein M, Wolf J, Kobe C.

J Nucl Med. 2011 Dec;52(12):1871-7. doi: 10.2967/jnumed.111.094458. Epub 2011 Nov 7.

15.

Role of combined 18F-FDG-PET/CT for predicting the WHO malignancy grade of thymic epithelial tumors: a multicenter analysis.

Lococo F, Cesario A, Okami J, Cardillo G, Cavuto S, Tokunaga T, Apolone G, Margaritora S, Granone P.

Lung Cancer. 2013 Nov;82(2):245-51. doi: 10.1016/j.lungcan.2013.08.003. Epub 2013 Aug 13.

PMID:
23992878
16.

18-Fluorine fluorodeoxyglucose positron emission tomography in the pretreatment evaluation of thymic epithelial neoplasms: a metabolic biopsy confirmed by Ki-67 expression.

Viti A, Bertolaccini L, Cavallo A, Fortunato M, Bianchi A, Terzi A.

Eur J Cardiothorac Surg. 2014 Sep;46(3):369-74; discussion 374. doi: 10.1093/ejcts/ezu030. Epub 2014 Feb 28.

PMID:
24585679
17.

18F-fluorodeoxyglucose positron emission tomography/computed tomography and the relationship between fluorodeoxyglucose uptake and the expression of hypoxia-inducible factor-1α, glucose transporter-1 and vascular endothelial growth factor in thymic epithelial tumours.

Toba H, Kondo K, Sadohara Y, Otsuka H, Morimoto M, Kajiura K, Nakagawa Y, Yoshida M, Kawakami Y, Takizawa H, Kenzaki K, Sakiyama S, Bando Y, Tangoku A.

Eur J Cardiothorac Surg. 2013 Aug;44(2):e105-12. doi: 10.1093/ejcts/ezt263. Epub 2013 May 14.

PMID:
23674658
18.

Changes in 18F-fluorodeoxyglucose and 18F-fluorodeoxythymidine positron emission tomography imaging in patients with non-small cell lung cancer treated with erlotinib.

Mileshkin L, Hicks RJ, Hughes BG, Mitchell PL, Charu V, Gitlitz BJ, Macfarlane D, Solomon B, Amler LC, Yu W, Pirzkall A, Fine BM.

Clin Cancer Res. 2011 May 15;17(10):3304-15. doi: 10.1158/1078-0432.CCR-10-2763. Epub 2011 Mar 1.

19.

Biologic correlation of 2-[18F]-fluoro-2-deoxy-D-glucose uptake on positron emission tomography in thymic epithelial tumors.

Kaira K, Endo M, Abe M, Nakagawa K, Ohde Y, Okumura T, Takahashi T, Murakami H, Tsuya A, Nakamura Y, Naito T, Hayashi I, Serizawa M, Koh Y, Hanaoka H, Tominaga H, Oriuchi N, Kondo H, Nakajima T, Yamamoto N.

J Clin Oncol. 2010 Aug 10;28(23):3746-53. doi: 10.1200/JCO.2009.27.4662. Epub 2010 Jul 12.

20.

Utility of 18FDG-PET for differentiating the grade of malignancy in thymic epithelial tumors.

Endo M, Nakagawa K, Ohde Y, Okumura T, Kondo H, Igawa S, Nakamura Y, Tsuya A, Murakami H, Takahashi T, Yamamoto N, Ito I, Kameya T.

Lung Cancer. 2008 Sep;61(3):350-5. doi: 10.1016/j.lungcan.2008.01.003. Epub 2008 Mar 4.

PMID:
18304691
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk